Global Coronary Angiography Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Angiography Systems, Angiography Catheters, Angiography Contrast Media, Vascular Closure Devices (VCDs), Angiography Balloons, Angiography Guidewires and Angiography Accessories.By Devices;
Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), Conventional Angiography, Digital Subtraction Angiography (DSA), Catheter Angiography, Coronary Angiography and Others.By Procedure;
Coronary Angiography, Endovascular Angiography, Peripheral Vascular Angiography and Other Angiography Procedures.By Technology;
X-Ray Angiography, CT Angiography, MR Angiography and Other Angiography Technologies.By Indication;
Coronary Artery Disease, Valvular Heart Disease, Congenital Heart Disease, Congestive Heart Failure and Other Indications.By End-User;
Hospitals And Clinics, Diagnostic And Imaging Centers and Research Institutes.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Coronary Angiography Devices Market (USD Million), 2021 - 2031
In the year 2024, the Global Coronary Angiography Devices Market was valued at USD 8,150.71 million. The size of this market is expected to increase to USD 12,317.29 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.1%.
The global coronary angiography devices market is experiencing significant growth due to the rising prevalence of cardiovascular diseases, technological advancements in medical imaging, and an increasing aging population. Coronary angiography, a critical procedure for diagnosing and managing heart conditions, involves the use of specialized devices to visualize the coronary arteries. This procedure enables the identification of blockages and abnormalities, facilitating timely and effective treatment. The market encompasses various types of angiography devices, including computed tomography (CT) angiography, magnetic resonance angiography (MRA), and traditional catheter-based methods, each contributing to the comprehensive assessment of coronary health.
In recent years, the market has been driven by innovations such as minimally invasive techniques, improved imaging quality, and the integration of artificial intelligence in diagnostic procedures. These advancements have enhanced the accuracy, efficiency, and safety of coronary angiography, leading to broader adoption and increased demand. Additionally, growing healthcare infrastructure in emerging economies and rising awareness about cardiovascular health are contributing to market expansion. As healthcare providers continue to prioritize early diagnosis and intervention for heart diseases, the global coronary angiography devices market is poised for sustained growth, addressing the critical needs of patients worldwide.
Global Coronary Angiography Devices Market Recent Developments
- In March 2020, inepict Health obtained FDA 510(k) clearance for its KMIT software (Kinepict Medical Imaging Tool), which utilizes Digital Variance Angiography (DVA) for advanced medical imaging applications
- In April 2022, GE Healthcare introduced the Discovery IGS 740 mobile angiography system, offering enhanced room design and flexibility. Its rail-free design and wide-bore C-arm positioning ensure comfort and control, while the large detector captures large anatomies in both 2D and 3D.
Segment Analysis
The global coronary angiography devices market is segmented based on product type, technology, end user, and region. By product type, the market includes computed tomography (CT) angiography, magnetic resonance angiography (MRA), X-ray angiography, and catheter-based angiography devices. Among these, CT angiography holds a significant market share due to its non-invasive nature, high-resolution imaging capabilities, and quick processing times. Magnetic resonance angiography is also gaining traction owing to its ability to provide detailed images without the use of ionizing radiation, making it suitable for patients with specific contraindications to traditional methods.
From a technology perspective, the market is divided into digital and analog systems, with digital systems dominating due to their enhanced image quality, ease of integration with hospital information systems, and better storage capabilities. End users of coronary angiography devices include hospitals, diagnostic centers, and ambulatory surgical centers. Hospitals account for the largest share owing to the high volume of procedures performed and the availability of advanced infrastructure and skilled professionals. Geographically, North America leads the market due to the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and strong presence of major market players. However, Asia-Pacific is anticipated to witness the fastest growth, driven by improving healthcare facilities, increasing healthcare expenditure, and rising awareness about early diagnosis and treatment of heart diseases.
Global Coronary Angiography Devices Market Analysis
In this report, the Global Coronary Angiography Devices Market has been segmented by Product, Devices, Procedure, Technology, Indication, End-User and Geography.
Global Coronary Angiography Devices Market, Segmentation by Product
The Global Coronary Angiography Devices Market has been segmented by Product into Angiography Systems, Angiography Catheters, Angiography Contrast Media, Vascular Closure Devices (VCDs), Angiography Balloons, Angiography Guidewires and Angiography Accessories.
The global coronary angiography devices market by product is broadly categorized into angiography systems, angiography catheters, angiography contrast media, vascular closure devices (VCDs), angiography balloons, angiography guidewires, and angiography accessories. Angiography systems, including CT angiography, magnetic resonance angiography (MRA), and traditional X-ray angiography, form the backbone of coronary imaging. These systems have seen significant advancements in imaging quality and processing speed, making them essential for accurate diagnosis and treatment planning. Angiography catheters are crucial for the delivery of contrast media and for navigating the coronary arteries. Their design innovations have led to better maneuverability and reduced patient discomfort, which is pivotal in complex procedures.
Angiography contrast media play a vital role in enhancing the visibility of coronary arteries during imaging. The development of safer and more effective contrast agents has minimized adverse reactions, thus improving patient outcomes. Vascular closure devices (VCDs) are used post-procedure to achieve hemostasis at the puncture site, promoting faster patient recovery and reducing complications. Angiography balloons are employed for dilating narrowed coronary arteries, while angiography guidewires aid in navigating through complex arterial pathways to reach target sites. The market also includes various angiography accessories such as introducer sheaths, injectors, and pressure monitoring devices, all of which contribute to the efficiency and safety of coronary angiography procedures. Together, these product segments cater to a wide range of clinical needs, driving the overall growth and evolution of the coronary angiography devices market.
Global Coronary Angiography Devices Market, Segmentation by Devices
The Global Coronary Angiography Devices Market has been segmented by Devices into Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), Conventional Angiography, Digital Subtraction Angiography (DSA), Catheter Angiography, Coronary Angiography and Others.
The global coronary angiography devices market encompasses a diverse range of imaging modalities, including Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), Conventional Angiography, Digital Subtraction Angiography (DSA), Catheter Angiography, and other advanced techniques. The increasing adoption of non-invasive imaging modalities such as MRA and CTA presents significant opportunities for market growth. MRA holds promise as a safe, noninvasive, and efficient test for evaluating the coronary arteries, offering a viable alternative to conventional angiography. Technical advancements, including faster imaging sequences and prospective double-blinded studies, are crucial for evaluating the full extent of MRA's clinical usefulness. Similarly, CTA has emerged as a faster, less invasive imaging technique associated with a smaller number of complications, positioning it as a valuable tool for coronary angiography. The continuous evolution of these non-invasive imaging modalities, coupled with their ability to provide detailed information about the blood vessels and their anatomic relationships, underscores their potential to drive the expansion of the global coronary angiography devices market.
The market for coronary angiography devices is influenced by the ongoing advancements in digital angiography systems, which augment conventional DSA by providing three-dimensional spatial information using tomosynthesis algorithms. Despite the emergence of alternative angiographic imaging techniques such as MRI and ultrasound angiography, x-ray angiography remains the predominant vascular imaging modality, generating substantial revenue in U.S. hospitals. The integration of advanced imaging technologies and the continuous refinement of angiographic imaging techniques contribute to the market's growth by enhancing the precision and diagnostic capabilities of coronary angiography devices. Additionally, the comparative analysis of MRA and multi-slice CT for ruling out significant coronary artery disease (CAD) highlights the potential of these non-invasive imaging modalities in providing accurate evaluations of patients with known or suspected CAD, further underscoring their significance in shaping the global coronary angiography devices market.
Global Coronary Angiography Devices Market, Segmentation by Procedure
The Global Coronary Angiography Devices Market has been segmented by Procedure into Coronary Angiography, Endovascular Angiography, Peripheral Vascular Angiography and Other Angiography Procedures.
The global coronary angiography devices market can be segmented by procedure into coronary angiography, endovascular angiography, peripheral vascular angiography, and other angiography procedures. Coronary angiography is the most prevalent procedure within this segment, primarily used to diagnose and manage coronary artery disease. It involves the visualization of the coronary arteries to detect blockages or abnormalities that may lead to heart attacks or other cardiac conditions. The high incidence of cardiovascular diseases worldwide has led to a significant increase in the number of coronary angiography procedures, driving demand for advanced and precise imaging devices.
Endovascular angiography, which involves imaging of blood vessels within various parts of the body to detect aneurysms, blockages, or other vascular conditions, is another critical segment. This procedure is often used in conjunction with interventions such as stent placement or balloon angioplasty. Peripheral vascular angiography focuses on the arteries and veins outside of the heart and brain, commonly used to diagnose conditions like peripheral artery disease (PAD). Other angiography procedures encompass a wide range of diagnostic imaging techniques for various vascular regions, including cerebral, renal, and pulmonary arteries. These procedures are essential for comprehensive vascular assessment and intervention, contributing to the overall growth and diversification of the angiography devices market. The increasing prevalence of vascular diseases, coupled with advancements in imaging technology and minimally invasive techniques, continues to expand the scope and application of these procedures globally.
Global Coronary Angiography Devices Market, Segmentation by Technology
The Global Coronary Angiography Devices Market has been segmented by Technology into X-Ray Angiography, CT Angiography, MR Angiography and Other Angiography Technologies.
The global coronary angiography devices market by technology includes X-ray angiography, computed tomography (CT) angiography, magnetic resonance (MR) angiography, and other angiography technologies. X-ray angiography, which encompasses digital subtraction angiography (DSA) and traditional catheter-based techniques, remains the gold standard for coronary imaging. It provides real-time, high-resolution images of the coronary arteries, facilitating precise diagnosis and intervention. The advancements in digital imaging and the integration of three-dimensional reconstruction have further enhanced the accuracy and efficacy of X-ray angiography, maintaining its widespread use in clinical practice.
CT angiography is gaining prominence due to its non-invasive nature and ability to produce detailed images quickly. This technology utilizes advanced CT scanners to capture multiple cross-sectional images of the coronary arteries, which are then reconstructed into a 3D model. This allows for a comprehensive assessment of coronary artery disease, including the detection of calcified plaques and evaluation of vessel patency. MR angiography, while less commonly used for coronary imaging compared to other modalities, offers the advantage of not using ionizing radiation. It is particularly beneficial for patients with contraindications to contrast media used in CT and X-ray angiography. MR angiography provides detailed images of blood vessels and is increasingly being utilized for complex cases requiring a detailed vascular assessment. Other angiography technologies, including ultrasound-based techniques and nuclear imaging, are also contributing to the market by offering alternative diagnostic options for specific patient populations and clinical scenarios. Collectively, these technological advancements are driving the growth and diversification of the coronary angiography devices market, enabling more precise and tailored diagnostic and therapeutic approaches.
Global Coronary Angiography Devices Market, Segmentation by Indication
The Global Coronary Angiography Devices Market has been segmented by Indication into Coronary Artery Disease, Valvular Heart Disease, Congenital Heart Disease, Congestive Heart Failure and Other Indications.
The global coronary angiography devices market by indication is categorized into coronary artery disease, valvular heart disease, congenital heart disease, congestive heart failure, and other indications. Coronary artery disease (CAD) is the most significant segment, driven by the high prevalence of this condition globally. CAD involves the narrowing or blockage of coronary arteries due to plaque buildup, leading to reduced blood flow to the heart. Coronary angiography is a critical diagnostic tool for CAD, enabling precise visualization of the extent and severity of arterial blockages. The increasing incidence of CAD, coupled with the growing emphasis on early diagnosis and intervention, is fueling the demand for advanced coronary angiography devices.
Valvular heart disease, which involves damage or defects in one or more of the heart's valves, is another major indication for coronary angiography. This procedure helps in assessing the functionality and structure of the heart valves, guiding the management and treatment strategies such as valve repair or replacement. Congenital heart disease, referring to structural defects in the heart present from birth, also necessitates the use of coronary angiography to plan surgical or interventional procedures. Congestive heart failure, a condition where the heart is unable to pump blood effectively, often requires detailed coronary imaging to evaluate the underlying causes and guide treatment. Other indications for coronary angiography include various cardiovascular conditions that demand detailed arterial imaging for accurate diagnosis and management. The broad application of coronary angiography across these diverse indications underscores its critical role in modern cardiology, driving continuous advancements and growth in the global coronary angiography devices market.
Global Coronary Angiography Devices Market, Segmentation by End-User
The Global Coronary Angiography Devices Market has been segmented by End-User into Hospitals And Clinics, Diagnostic And Imaging Centers and Research Institutes.
The global coronary angiography devices market, segmented by end-users into hospitals and clinics, diagnostic and imaging centers, and research institutes, reflects the diverse landscape of healthcare facilities utilizing these advanced imaging technologies. Hospitals and clinics represent a significant share of the market, driven by the large patient pool diagnosed and treated at these facilities, their high purchasing capacity for advanced technologies, and the increasing number of diagnostic and therapeutic angiographic procedures. The pivotal role of hospitals and clinics in providing comprehensive cardiovascular care, coupled with the growing awareness of timely disease diagnosis, underscores their prominence in shaping the market dynamics. Additionally, the demand for coronary angiography devices in diagnostic and imaging centers is notable, as these facilities cater to a wide range of patients requiring diagnostic imaging services. The rising patient visits to diagnostic imaging centers have led to the dominance of this segment, reflecting the increasing demand for visual representations of the interior of the body for diagnostic and therapeutic purposes. Furthermore, research institutes contribute to the market by driving advancements in imaging technology and conducting studies to enhance the efficacy and safety of coronary angiography devices, thereby playing a crucial role in shaping the future landscape of the global coronary angiography devices market.
The market's segmentation by end-users reflects the multifaceted utilization of coronary angiography devices across various healthcare settings, each contributing to the market's growth in distinct ways. The prevalence of coronary artery disease (CAD) and the increasing demand for less-invasive imaging modalities have propelled the adoption of coronary angiography in hospitals, clinics, and diagnostic centers, highlighting the pivotal role of these end-users in driving market expansion. Moreover, the continuous development in imaging technology for various applications in the healthcare industry, coupled with the rising awareness about cardiovascular diseases and associated risk factors, is expected to further drive the market. The joint initiatives of global health organizations and state governments to increase awareness about heart diseases and their underlying causes are anticipated to contribute to the growth of the angiography equipment market. As the medical imaging industry experiences robust global expansion, the utilization of coronary angiography devices across diverse end-user settings reflects the evolving landscape of cardiovascular care and diagnostic imaging, positioning these facilities as key drivers of the global coronary angiography devices market's growth.
Global Coronary Angiography Devices Market, Segmentation by Geography
In this report, the Global Coronary Angiography Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Coronary Angiography Devices Market Share (%), by Geographical Region, 2024
The global coronary angiography devices market is segmented geographically into five key regions: North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America holds the largest share of the market, driven by a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and substantial healthcare expenditure. The United States, in particular, is a significant contributor due to the presence of major market players, ongoing technological innovations, and a robust regulatory framework that ensures high standards of medical device safety and efficacy. Additionally, increasing awareness about early diagnosis and preventive care contributes to the high demand for coronary angiography devices in this region.
Europe is another major market, characterized by a well-established healthcare system and widespread adoption of advanced diagnostic technologies. Countries like Germany, France, and the United Kingdom are leading in terms of market share due to their strong focus on research and development and the presence of numerous specialized cardiac care centers. The Asia Pacific region is expected to witness the fastest growth, driven by rising healthcare investments, improving healthcare infrastructure, and increasing prevalence of cardiovascular diseases. Countries such as China, India, and Japan are significant contributors to this growth, with increasing awareness and adoption of advanced medical technologies. The Middle East and Africa and Latin America regions are also experiencing growth, albeit at a slower pace, due to improving healthcare facilities, economic development, and growing awareness about heart diseases. These regions present substantial opportunities for market expansion as healthcare access and quality continue to improve.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Coronary Angiography Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Rising Prevalence of Cardiovascular Diseases
- Technological Advancements in Medical Imaging
- Increasing Aging Population
-
Advancements in Minimally Invasive Techniques: Advancements in minimally invasive techniques have revolutionized the field of coronary angiography, offering patients safer and more comfortable alternatives to traditional invasive procedures. Minimally invasive techniques involve smaller incisions, reduced trauma to surrounding tissues, and faster recovery times, making them increasingly preferred by both patients and healthcare providers. One notable advancement is the development of transradial access, where the catheter is inserted through the radial artery in the wrist instead of the femoral artery in the groin. This technique not only reduces the risk of complications such as bleeding and vascular injury but also allows for same-day discharge, enhancing patient satisfaction and reducing healthcare costs. Additionally, innovations in catheter technology, such as the use of thinner and more flexible catheters, enable smoother navigation through complex arterial pathways, improving procedural success rates and patient outcomes.
The introduction of robotic-assisted coronary angiography systems has further refined minimally invasive techniques, offering greater precision and control during procedures. These systems allow cardiologists to perform coronary interventions with enhanced dexterity and accuracy, particularly in challenging anatomical locations. Moreover, advancements in imaging technology, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), provide real-time visualization of coronary arteries, allowing for more accurate assessment of lesion morphology and stent deployment. These technological advancements not only improve procedural outcomes but also contribute to the expansion of the coronary angiography devices market by attracting more patients and healthcare providers to embrace minimally invasive approaches for coronary interventions.
Restraints:
- High Cost of Angiography Procedures and Devices
- Risk of Complications and Adverse Reactions
- Stringent Regulatory Approvals and Compliance
-
Limited Access to Advanced Healthcare Facilities in Developing Regions: Limited access to advanced healthcare facilities in developing regions presents a significant challenge for the global coronary angiography devices market. The high cost of equipment and limited healthcare budgets in these regions hinder the widespread adoption of angiography devices, thereby impeding market growth. Developing countries face financial constraints and limited access to healthcare facilities, which are major factors hampering the adoption of angiography equipment. Additionally, the lack of skilled professionals and concerns about contrast agents further contribute to the challenges faced in these regions. The impact of COVID-19 has also affected the market, leading to a period of stagnation due to disrupted procurement and supply chains, as well as the temporary closure of manufacturing facilities. Despite these challenges, there are opportunities for market penetration in countries like Mexico, India, and China, where major companies are seeking to establish a presence, indicating the potential for future growth in these regions.
The Asia Pacific region is anticipated to witness substantial growth in the angiography equipment market due to the rising number of cardiovascular disease cases and increased investments in the healthcare sector. Efforts to enhance healthcare facilities and investments in developing regions, coupled with the rising awareness about early disease detection and improving access to healthcare, are expected to contribute to the market's growth. Furthermore, the presence of advanced healthcare systems in developed regions allows for a larger adoption of new and advanced angiography equipment, positioning these regions as significant contributors to the market. Despite the challenges posed by limited access to advanced healthcare facilities in developing regions, the continuous development in imaging technology and the increasing awareness about cardiovascular diseases and their risk factors are expected to drive the market's growth, offering potential opportunities for the expansion of coronary angiography devices in these regions.
Opportunities:
- Development of Cost-Effective and Portable Devices
- Integration of Telemedicine and Remote Monitoring
- Advancements in 3D Imaging and Visualization Techniques
-
Collaborations and Partnerships in R&D: Collaborations and partnerships in research and development (R&D) play a pivotal role in driving innovation and accelerating the pace of advancements in the global coronary angiography devices market. By joining forces, companies can leverage each other's expertise, resources, and technological capabilities to tackle complex challenges and bring novel solutions to market more efficiently. Collaborations between medical device manufacturers and academic institutions or research organizations enable the exchange of scientific knowledge and insights, fostering a collaborative environment conducive to breakthrough discoveries. These partnerships often result in the development of cutting-edge technologies, such as next-generation imaging systems, advanced catheter designs, and innovative contrast media formulations, which significantly enhance the diagnosis and treatment of coronary artery disease.
Collaborations and partnerships in R&D also facilitate access to a broader pool of patient data and clinical expertise, enabling more robust clinical validation and regulatory approval processes. By conducting multi-center clinical trials and studies involving diverse patient populations, companies can generate robust evidence supporting the safety, efficacy, and clinical utility of their coronary angiography devices. Furthermore, strategic collaborations between medical device manufacturers and healthcare providers enable the co-development of customized solutions tailored to address specific clinical needs and preferences. These partnerships not only drive product differentiation and competitive advantage but also foster long-term relationships with key opinion leaders and healthcare decision-makers, positioning companies for sustained growth and success in the dynamic global coronary angiography devices market.
Competitive Landscape Analysis
Key players in Global Coronary Angiography Devices Market include:
- Terumo,
- Boston Scientific Corporation,
- Canon Medical Systems,
- Cordis (A Cardinal Health Company),
- Angiodynamics,
- Abbott Vascular,
- Toshiba Medical Systems Corporation,
- Royal Philips Electronics,
- GE Healthcare,
- Medtronic, Inc.,
- Shimadzu Corporation
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Devices
- Market Snapshot, By Procedure
- Market Snapshot, By Technology
- Market Snapshot, By Indication
- Market Snapshot, By End-User
- Market Snapshot, By Region
- Global Coronary Angiography Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Rising Prevalence of Cardiovascular Diseases
-
Technological Advancements in Medical Imaging
-
Increasing Aging Population
-
Advancements in Minimally Invasive Techniques
-
- Restraints
-
High Cost of Angiography Procedures and Devices
-
Risk of Complications and Adverse Reactions
-
Stringent Regulatory Approvals and Compliance
-
Limited Access to Advanced Healthcare Facilities in Developing Regions
-
- Opportunities
-
Development of Cost-Effective and Portable Devices
-
Integration of Telemedicine and Remote Monitoring
-
Advancements in 3D Imaging and Visualization Techniques
-
Collaborations and Partnerships in R&D
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Coronary Angiography Devices Market, By Product, 2021 - 2031 (USD Million)
- Angiography Systems
- Angiography Catheters
- Angiography Contrast Media
- Vascular Closure Devices (VCDs)
- Angiography Balloons
- Angiography Guidewires
- Angiography Accessories
- Global Coronary Angiography Devices Market, By Devices, 2021 - 2031 (USD Million)
- Magnetic Resonance Angiography (MRA)
- Computed Tomography Angiography (CTA)
- Conventional Angiography
- Digital Subtraction Angiography (DSA)
- Catheter Angiography
- Coronary Angiography
- Global Coronary Angiography Devices Market, By Procedure, 2021 - 2031 (USD Million)
- Coronary Angiography
- Endovascular Angiography
- Peripheral Vascular Angiography
- Other Angiography Procedures
- Global Coronary Angiography Devices Market, By Technology, 2021 - 2031 (USD Million)
- X-Ray Angiography
- CT Angiography
- MR Angiography
- Other Angiography Technologies
- Global Coronary Angiography Devices Market, By Indication, 2021 - 2031 (USD Million)
- Coronary Artery Disease
- Valvular Heart Disease
- Congenital Heart Disease
- Congestive Heart Failure
- Global Coronary Angiography Devices Market, By End-User, 2021 - 2031 (USD Million)
- Hospitals And Clinics
- Diagnostic And Imaging Centers
- Research Institutes
- Global Coronary Angiography Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Coronary Angiography Devices Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Terumo
- Boston Scientific Corporation
- Canon Medical Systems
- Cordis (A Cardinal Health Company)
- Angiodynamics
- Abbott Vascular
- Toshiba Medical Systems Corporation
- Royal Philips Electronics
- GE Healthcare
- Medtronic, Inc.
- Shimadzu Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market